The evolving role of immune checkpoint inhibitors in cutaneous squamous cell carcinoma: Across the disease spectrum
Immune-checkpoint inhibitors (ICIs) have an established role as the primary treatment for advanced cutaneous squamous cell carcinoma (cSCC) with deep, durable and rapid responses. Their integration into the multidisciplinary management of resectable cSCC is expanding with positive studies in the per...
Furkejuvvon:
| Váldodahkkit: | , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Elsevier
2025-01-01
|
| Ráidu: | EJC Skin Cancer |
| Fáttát: | |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S2772611825004902 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|